Evidence map›Paper›PMID 28746305›Full record

ArticleNature2017

Stimulation of functional neuronal regeneration from Müller glia in adult mice.

Nikolas L Jorstad, Matthew S Wilken, William N Grimes, Stefanie G Wohl, Leah S VandenBosch, Takeshi Yoshimatsu, Rachel O Wong, Fred Rieke, Thomas A Reh

Open access · greenAbstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 299 papers.

0numbers the graph read from it
0cells of the map it votes in
299citing papers in PubMed
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

299 citing papers in PubMed, 516 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mesenchymal-derived neural progenitors underlie localbioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. eLife · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Review

239 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nikolas L JorstadDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
Matthew S WilkenDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
William N GrimesDepartment of Physiology and Biophysics, University of Washington, Seattle, Washington 98195, USA.
Stefanie G WohlDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
Leah S VandenBoschDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
Takeshi YoshimatsuDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
Rachel O WongDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
Fred RiekeDepartment of Physiology and Biophysics, University of Washington, Seattle, Washington 98195, USA.
Thomas A RehDepartment of Biological Structure, University of Washington, Seattle, Washington 98195, USA.
Seattle University · USUniversity of Washington · USHoward Hughes Medical Institute · US

Funding

Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI MAUREEN E NEITZ · 1985 to 2026
$23.5M
TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
Supplement to EY021482 to carry out a screen for retinal regeneration using CRISPR-Cas9 gene activation.R01EY021482 · NEI · UNIVERSITY OF WASHINGTON · PI THOMAS A REH · 2011 to 2026
$6.3M
In Vivo Analysis of the Developing Vertebrate RetinaR01EY014358 · NEI · WASHINGTON UNIVERSITY · PI WONG, RACHEL O · 2003 to 2016
$4.3M
Howard Hughes Medical InstituteNEI NIH HHS P30 EY001730NEI NIH HHS R01 EY014358NEI NIH HHS R01 EY021482NIGMS NIH HHS T32 GM007270NIH HHS EY14358
6 · The paper itself

Abstract

Many retinal diseases lead to the loss of retinal neurons and cause visual impairment. The adult mammalian retina has little capacity for regeneration. By contrast, teleost fish functionally regenerate their retina following injury, and Müller glia (MG) are the source of regenerated neurons. The proneural transcription factor Ascl1 is upregulated in MG after retinal damage in zebrafish and is necessary for regeneration. Although Ascl1 is not expressed in mammalian MG after injury, forced expression of Ascl1 in mouse MG induces a neurogenic state in vitro and in vivo after NMDA (N-methyl-d-aspartate) damage in young mice. However, by postnatal day 16, mouse MG lose neurogenic capacity, despite Ascl1 overexpression. Loss of neurogenic capacity in mature MG is accompanied by reduced chromatin accessibility, suggesting that epigenetic factors limit regeneration. Here we show that MG-specific overexpression of Ascl1, together with a histone deacetylase inhibitor, enables adult mice to generate neurons from MG after retinal injury. The MG-derived neurons express markers of inner retinal neurons, synapse with host retinal neurons, and respond to light. Using an assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq), we show that the histone deacetylase inhibitor promotes accessibility at key gene loci in the MG, and allows more effective reprogramming. Our results thus provide a new approach for the treatment of blinding retinal diseases.

Indexed as

Nerve RegenerationNeurogenesisAnimalsBasic Helix-Loop-Helix ProteinsEpistasis, GeneticFemaleHistone Deacetylase InhibitorsHydroxamic AcidsMaleMiceNeural PathwaysNeurogliaNeuronsRetinaSynapsesAscl1 protein, mouseBasic Helix-Loop-Helix ProteinsHistone Deacetylase InhibitorsHydroxamic Acidstrichostatin A

Identifiers

PMID28746305
PMCPMC5991837
OpenAlexW2737675606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.